Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up.

  title={Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up.},
  author={Agnes van Sonderen and Roland D. Thijs and Elias C Coenders and Lize C. Jiskoot and Esther S{\'a}nchez and Marienke A A M de Bruijn and Marleen H. van Coevorden-Hameete and Paul Willem Wirtz and Marco W. J. Schreurs and Peter A. E. Sillevis Smitt and Maarten J. Titulaer},
  volume={87 14},
OBJECTIVE This nationwide study gives a detailed description of the clinical features and long-term outcome of anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis. METHODS We collected patients prospectively from October 2013, and retrospectively from samples sent to our laboratory from January 2007. LGI1 antibodies were confirmed with both cell-based assay and immunohistochemistry. Clinical information was obtained in interviews with patients and their relatives and from medical… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 10 times over the past 90 days. VIEW TWEETS